Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:MSLI

(MSLI) (MSLI) Stock Price, News & Analysis

(MSLI) logo

About (MSLI) Stock (NASDAQ:MSLI)

Key Stats

Today's Range
$1.30
$1.30
50-Day Range
N/A
52-Week Range
$0.70
$1.33
Volume
N/A
Average Volume
56,140 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Merus Labs International Inc. is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company's products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin. Elantan are tablets or capsules that belong to a group of medicines called organic nitrates. Isoket belongs to a group of medicines called organic nitrates. Deponit belongs to a group of medicines called nitrates. Sintrom is an anticoagulant indicated to treat and prevent thromboembolic diseases. Emselex/Enablex is used in adults to treat overactive bladder syndrome. Surgestone is used to treat women with menstrual irregularities due to ovulation disorder, dysmenorrhea and premenstrual syndrome. Provames is used as hormone replacement therapy in postmenopausal women with symptoms of estrogen deficiency.

Receive MSLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (MSLI) and its competitors with MarketBeat's FREE daily newsletter.

MSLI Stock News Headlines

We recommended Palantir in 2021, now we’re recommending this...
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
See More Headlines

MSLI Stock Analysis - Frequently Asked Questions

(MSLI) (NASDAQ:MSLI) announced its earnings results on Monday, August, 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by $0.03. The company earned $7.73 million during the quarter, compared to analysts' expectations of $17.19 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that (MSLI) investors own include ProMetic Life Sciences (PLI), Palatin Technologies (PTN), Anavex Life Sciences (AVXL), Biocept (BIOC), Can-Fite BioPharma (CANF), InterCloud Systems (ICLD) and Merus Labs International (MSL).

Company Calendar

Last Earnings
8/10/2015
Today
12/23/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:MSLI
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:MSLI) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners